The most common arrhythmia is atrial fibrillation, which happens when the heart's upper chambers (atria) receive irregular electrical impulses. As a result, the beat becomes irregular and rapid. A heart rate of 100 to 175 beats per minute can be caused by atrial fibrillation. Atrial fibrillation causes confusion, dizziness, tiredness, and fainting. Other factors that enhance the incidence of AF include the increased global prevalence of obesity and cardiac disorders, in addition to COVID-19's recent development and influence on AF.
Frequently Asked Questions
The major factors driving the growth of the Atrial Fibrillation market are increase in elderly population and increase in developed treatments
The primary challenges include helping in outgrowing the market size but one factor that is limiting the growth is the excessive high price of the treatment process. It is costly and thus it is not applicable every time to use it tremendously.
The United States is expected to dominate the global atrial fibrillation market, particularly in North America. This dominance is attributed to the country's advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and a growing prevalence of atrial fibrillation due to an aging population.
North America dominates the atrial fibrillation market due to the rapidly rising number of healthcare expenditure along with prevalence of improved infrastructure.
The United States is expected to dominate the global atrial fibrillation market, particularly in North America. This dominance is attributed to the country's advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and a growing prevalence of atrial fibrillation due to an aging population.
